Correlates of valvular ossification in patients with aortic valve stenosis

Clinical and Translational Science

Volumn 2, Issue 6, 2009, Pages 431-435

  Ing, Steven W ^a   Mohler III, Emile R ^b   Putt, Mary E ^b   Torigian, Drew ^b   Leonard, Mary B ^c  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Aortic stenosis; Calcification; Ossification; Warfarin

Indexed keywords

WARFARIN;

ADULT; AFRICAN AMERICAN; AGED; AORTA STENOSIS; AORTA SUBVALVULAR STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; BODY HEIGHT; BODY MASS; CALCIFICATION; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; DIABETES MELLITUS; ENCHONDRAL OSSIFICATION; FEMALE; HEART INFARCTION; HEART OUTPUT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OBESITY; OSSIFICATION; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SKELETON; THORAX RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; BONE AND BONES; CALCINOSIS; CARDIOMYOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; YOUNG ADULT;

EID: 77953454377     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2009.00168.x     Document Type: Article

References (24)

1. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999, 341:142-147.
2. Kim KM. Apoptosis and calcification. Scanning Microsc. 1995, 9:1137-1175. discussion 1175-1178
3. Mohler ER, Adam LP, McClelland P, Graham L, Hathaway DR. Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol. 1997, 17:547-552.
4. Srivatsa SS, Harrity PJ, Maercklein PB, Kleppe L, Veinot J, Edwards WD, Johnson CM, Fitzpatrick LA. Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves. J Clin Invest. 1997, 99:996-1009.
5. O'Brien KD, Kuusisto J, Reichenbach DD, Ferguson M, Giachelli C, Alpers CE, Otto CM. Osteo-pontin is expressed in human aortic valvular lesions. Circulation. 1995, 92:2163-2168.
6. Mohler ER, Chawla MK, Chang AW, Vyavahare N, Levy RJ, Graham L, Gannon FH. Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis. 1999, 8:254-260.
7. Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab. 2004, 286:E686-696.
8. Mohler ER, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation. 2001, 103:1522-1528.
9. Steiner I, Kasparova P, Kohout A, Dominik J. Bone formation in cardiac valves: a histopathological study of 128 cases. Virchows Arch. 2007, 450:653-657.
10. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976, 16:31-41.
11. Senac MO, Lee FA, Gilsanz V. Early costochondral calcification in adolescent hyperthyroi-dism. Radiology. 1985, 156:375-377.
12. Hosmer D, Lemeshow S. Model-Building Strategies and Methods for Logistic Regression. Applied Logistic Regression Analysis 2000, 91-142. In, New York, Wiley
13. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997, 29:630-634.
14. Pohle K, Maffert R, Ropers D, Moshage W, Stilianakis N, Daniel WG, Achenbach S. Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation. 2001, 104:1927-1932.
15. Palta S, Pai AM, Gill KS, Pai RG. New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation. 2000, 101:2497-2502.
16. Savitz DA, Olshan AF. Multiple comparisons and related issues in the interpretation of epidemiologic data. Am J Epidemiol. 1995, 142:904-908.
17. Shanahan CM, Proudfoot D, Farzaneh-Far A, Weissberg PL. The role of Gla proteins in vascular calcification. Crit Rev Eukaryot Gene Expr. 1998, 8:357-375.
18. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997, 386:78-81.
19. Bostrom K, Tsao D, Shen S, Wang Y, Demer LL. Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J Biol Chem. 2001, 276:14044-14052.
20. Price PA, Faus SA, Williamson MK. Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler Thromb Vasc Biol. 2000, 20:317-327.
21. Price PA, Faus SA, Williamson MK. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol. 2001, 21:817-824.
22. Knapen MH, Hellemons-Boode BS, Langenberg-Ledeboer M, Knottnerus JA, Hamulyak K, Price PA, Vermeer C. Effect of oral anticoagulant treatment on markers for calcium and bone metabolism. Haemostasis. 2000, 30:290-297.
23. Jamal SA, Browner WS, Bauer DC, Cummings SR. Warfarin use and risk for osteoporosis in elderly women. Study of Osteoporotic Fractures Research Group. Ann Intern Med. 1998, 128:829-832.
24. Schurgers LJ, Aebert H, Vermeer C, Bultmann B, Janzen J. Oral anticoagulant treatment: friend or foe in cardiovascular disease?. Blood. 2004, 104:3231-3232.